Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16318) 16318
Newsletter (53) 53
Newspaper Article (49) 49
Publication (8) 8
Book / eBook (5) 5
Magazine Article (4) 4
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15226) 15226
science & technology (12485) 12485
life sciences & biomedicine (11090) 11090
female (8936) 8936
male (8858) 8858
middle aged (7704) 7704
oncology (6826) 6826
aged (6801) 6801
tumors (6470) 6470
biological and medical sciences (6355) 6355
medical sciences (6248) 6248
stomach neoplasms - pathology (5220) 5220
stomach cancer (5173) 5173
adult (5158) 5158
cancer (5139) 5139
gastroenterology. liver. pancreas. abdomen (5064) 5064
stomach. duodenum. small intestine. colon. rectum. anus (4943) 4943
gastric cancer (4377) 4377
gastroenterology & hepatology (3144) 3144
stomach neoplasms - immunology (3106) 3106
prognosis (2915) 2915
medicine & public health (2750) 2750
aged, 80 and over (2719) 2719
surgery (2646) 2646
stomach neoplasms - genetics (2301) 2301
animals (2300) 2300
gastroenterology (2220) 2220
immunohistochemistry (2138) 2138
analysis (2121) 2121
colorectal cancer (1965) 1965
research (1918) 1918
stomach neoplasms - surgery (1898) 1898
neoplasm staging (1837) 1837
pathology (1832) 1832
metastasis (1824) 1824
stomach neoplasms - metabolism (1691) 1691
risk factors (1671) 1671
medicine (1664) 1664
research article (1655) 1655
cell line, tumor (1647) 1647
mice (1518) 1518
health aspects (1428) 1428
science & technology - other topics (1398) 1398
multidisciplinary sciences (1388) 1388
cancer research (1387) 1387
gene expression (1373) 1373
surgical oncology (1362) 1362
adenocarcinoma - pathology (1351) 1351
chemotherapy (1349) 1349
abridged index medicus (1340) 1340
treatment outcome (1321) 1321
retrospective studies (1316) 1316
stomach neoplasms - drug therapy (1300) 1300
science (1294) 1294
care and treatment (1263) 1263
genetic aspects (1256) 1256
stomach neoplasms - mortality (1227) 1227
immunology (1219) 1219
abdominal surgery (1218) 1218
helicobacter pylori (1144) 1144
medical prognosis (1125) 1125
proteins (1121) 1121
colorectal neoplasms - pathology (1103) 1103
gene expression regulation, neoplastic (1079) 1079
patients (1032) 1032
oncology, experimental (1016) 1016
follow-up studies (1001) 1001
development and progression (968) 968
apoptosis (960) 960
survival rate (950) 950
lymphatic metastasis (948) 948
stomach neoplasms - diagnosis (943) 943
survival analysis (918) 918
stomach neoplasms - microbiology (901) 901
case-control studies (889) 889
studies (866) 866
gastrectomy (850) 850
hepatology (841) 841
antineoplastic agents (789) 789
metastases (773) 773
cell biology (763) 763
stomach (758) 758
internal medicine (752) 752
multivariate analysis (750) 750
adenocarcinoma - immunology (743) 743
cell proliferation (735) 735
genes (735) 735
stomach neoplasms - therapy (735) 735
medical research (731) 731
pharmacology. drug treatments (729) 729
colonic neoplasms - immunology (724) 724
mutation (721) 721
neoplasm invasiveness (714) 714
cancer therapies (706) 706
helicobacter infections - complications (695) 695
biomarkers (688) 688
gastric mucosa - pathology (688) 688
cancers and neoplasms (687) 687
prospective studies (687) 687
diagnosis (676) 676
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15682) 15682
Japanese (859) 859
Chinese (235) 235
Russian (232) 232
German (67) 67
French (51) 51
Spanish (37) 37
Polish (35) 35
Italian (34) 34
Portuguese (10) 10
Croatian (4) 4
Czech (4) 4
Korean (4) 4
Romanian (4) 4
Hungarian (3) 3
Bulgarian (2) 2
Danish (2) 2
Dutch (2) 2
Finnish (2) 2
Swedish (2) 2
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients
by Anna Maria Wolf and Dominik Wolf and Michael Steurer and Guenther Gastl and Eberhard Gunsilius and Beatrix Grubeck-Loebenstein
Clinical Cancer Research, ISSN 1078-0432, 02/2003, Volume 9, Issue 2, pp. 606 - 612
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Breast Neoplasms - immunology | Humans | Lung Neoplasms - pathology | Reference Values | Stomach Neoplasms - pathology | Neoplasms - blood | Killer Cells, Natural - immunology | Female | Colorectal Neoplasms - blood | Genital Neoplasms, Female - blood | Genital Neoplasms, Female - immunology | Stomach Neoplasms - immunology | Antigens, CD - blood | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Stomach Neoplasms - blood | Breast Neoplasms - pathology | Neoplasms - immunology | Breast Neoplasms - blood | Lymphocyte Count | T-Lymphocytes - immunology | Lung Neoplasms - blood | Colorectal Neoplasms - pathology | Neoplasm Staging | Neoplasms - pathology | Genital Neoplasms, Female - pathology | Cytotoxicity, Immunologic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
by Ayers, Mark and Lunceford, Jared and Nebozhyn, Michael and Murphy, Erin and Loboda, Andrey and Kaufman, David R and Albright, Andrew and Cheng, Jonathan D and Kang, S. Peter and Shankaran, Veena and Piha-Paul, Sarina A and Yearley, Jennifer and Seiwert, Tanguy Y and Ribas, Antoni and McClanahan, Terrill K
The Journal of clinical investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2930 - 2940
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunohistochemistry | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Interferon-gamma - metabolism | Immune System | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Signal Transduction | Skin Neoplasms - immunology | Carcinoma - immunology | Programmed Cell Death 1 Receptor - metabolism | Treatment Outcome | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Carcinoma, Non-Small-Cell Lung - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Pilot Projects | Sequence Analysis, RNA | Biopsy | Melanoma - immunology | Melanoma - drug therapy | ROC Curve | Carcinoma, Non-Small-Cell Lung - drug therapy | PD-1 protein | Lung cancer | Clinical trials | Cytotoxicity | Biology | Lymphocytes T | Cancer therapies | Metastases | Lymphocytes | Adaptation | Antigen presentation | Squamous cell carcinoma | Cytokines | Melanoma | Inflammation | Gene expression | Immune checkpoint | PD-L1 protein | Head and neck cancer | Antitumor activity | Ligands | Interferon | Chemokines | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
by Ogitani, Yusuke and Hagihara, Katsunobu and Oitate, Masataka and Naito, Hiroyuki and Agatsuma, Toshinori
Cancer science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1039 - 1046
topoisomerase I inhibitor | T‐DM | HER2 | bystander killing | Antibody‐drug conjugate | T-DM | Antibody-drug conjugate | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, ErbB-2 - genetics | Breast Neoplasms - immunology | Humans | Ado-Trastuzumab Emtansine | Stomach Neoplasms - pathology | Maytansine - pharmacology | Immunoconjugates - immunology | Breast Neoplasms - enzymology | Immunoconjugates - pharmacology | Topoisomerase I Inhibitors - pharmacology | Neoplasms - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Camptothecin - immunology | Receptor, ErbB-2 - immunology | Camptothecin - analogs & derivatives | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Maytansine - analogs & derivatives | Neoplasms - enzymology | Stomach Neoplasms - immunology | Animals | Breast Neoplasms - genetics | Bystander Effect - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms - immunology | Cell Membrane Permeability - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal, Humanized - immunology | Neoplasms - pathology | Camptothecin - pharmacology | Maytansine - immunology | Trastuzumab | Viral antibodies | Epidermal growth factor | Imaging systems | Antibodies | Permeability | Drug therapy | Biopharmaceutics | Tumors | Antigens | Hematology | Laboratories | Toxicity | DNA topoisomerase | Polymerization | Clinical trials | Cytotoxicity | Breast cancer | ErbB-2 protein | Stomach cancer | Lymphoma | Hypotheses | Antitumor agents | Xenografts | Antitumor activity | Drug dosages | Payloads | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
by Murahashi, Mutsunori and Hijikata, Yasuki and Yamada, Kazunari and Tanaka, Yoshihiro and Kishimoto, Junji and Inoue, Hiroyuki and Marumoto, Tomotoshi and Takahashi, Atsushi and Okazaki, Toshihiko and Takeda, Kazuyoshi and Hirakawa, Masakazu and Fujii, Hiroshi and Okano, Shinji and Morita, Masaru and Baba, Eishi and Mizumoto, Kazuhiro and Maehara, Yoshihiko and Tanaka, Masao and Akashi, Koichi and Nakanishi, Yoichi and Yoshida, Koji and Tsunoda, Takuya and Tamura, Kazuo and Nakamura, Yusuke and Tani, Kenzaburo
Clinical immunology (Orlando, Fla.), ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | Life Sciences & Biomedicine | Immunology | Science & Technology | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy
by Li, Qing-Qing and Lu, Zhi-Hao and Yang, Li and Lu, Ming and Zhang, Xiao-Tian and Li, Jian and Zhou, Jun and Wang, Xi-Cheng and Gong, Ji-Fang and Gao, Jing and Li, Jie and Li, Yan and Shen, Lin
Asian Pacific journal of cancer prevention : APJCP, ISSN 1513-7368, 2014, Volume 15, Issue 2, pp. 945 - 950
Overall survival | Gastric cancer | Systemic inflammation | Glasgow prognostic score (GPS) | Life Sciences & Biomedicine | Oncology | Science & Technology | Inflammation - pathology | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Male | Stomach Neoplasms - pathology | Liver Neoplasms - mortality | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Inflammation - drug therapy | Inflammation Mediators - metabolism | Female | Liver Neoplasms - secondary | Inflammation - mortality | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Inflammation - immunology | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy
by Giampieri, Riccardo and Giampieri, Riccardo and Maccaroni, Elena and Maccaroni, Elena and Mandolesi, Alessandra and Mandolesi, Alessandra and Del Prete, Michela and Del Prete, Michela and Andrikou, Kalliopi and Andrikou, Kalliopi and Faloppi, Luca and Faloppi, Luca and Bittoni, Alessandro and Bittoni, Alessandro and Bianconi, Maristella and Bianconi, Maristella and Scarpelli, Marina and Scarpelli, Marina and Bracci, Raffaella and Bracci, Raffaella and Scartozzi, Mario and Scartozzi, Mario and Cascinu, Stefano and Cascinu, Stefano
Gastric Cancer, ISSN 1436-3291, 1/2017, Volume 20, Issue 1, pp. 156 - 163
Chemotherapy | Prognosis | Medicine & Public Health | Mismatch repair | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Microsatellite instability | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Microsatellite Instability | Follow-Up Studies | Humans | Male | Stomach Neoplasms - pathology | DNA Mismatch Repair - genetics | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Fluorouracil - administration & dosage | Lung Neoplasms - secondary | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Cancer patients | Care and treatment | Immune response | Patient outcomes | Immunotherapy | Metastasis | Stomach cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
by Gabitass, Rachel F and Annels, Nicola E and Stocken, Deborah D and Pandha, Hardev A and Middleton, Gary W
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 10/2011, Volume 60, Issue 10, pp. 1419 - 1430
Immunology | Medicine & Public Health | Cytokine | Interleukin-13 | Prognostic factor | Oncology | Cancer Research | Arginase | Myeloid-derived suppressor cell | Cancer | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Esophagus | Tumors | Pancreatic Neoplasms - blood | Prognosis | Enzyme-Linked Immunosorbent Assay | Cell Separation | Esophageal Neoplasms - blood | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Interleukin-13 - immunology | Immunophenotyping | Male | Th2 Cells - immunology | Esophageal Neoplasms - immunology | Stomach Neoplasms - immunology | Flow Cytometry | Stomach Neoplasms - blood | Myeloid Cells - immunology | Pancreatic Neoplasms - immunology | Esophageal Neoplasms - mortality | Female | Pancreatic Neoplasms - mortality | Stomach Neoplasms - mortality | Interleukin-13 - blood | Medical colleges | Care and treatment | Interleukins | Analysis | Oncology, Experimental | Research | Vascular endothelial growth factor | Stomach cancer | Esophageal cancer | Enzyme-linked immunosorbent assay | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text An overview of the association between allergy and cancer
by Turner, Michelle C and Chen, Yue and Krewski, Daniel and Ghadirian, Parviz
International journal of cancer, ISSN 0020-7136, 06/2006, Volume 118, Issue 12, pp. 3124 - 3132
epidemiology | allergy | neoplasms | etiology | Allergy | Etiology | Epidemiology | Neoplasms | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | General aspects | Biological and medical sciences | Allergic diseases | Medical sciences | Tumors | Humans | Glioma - immunology | Hypersensitivity - immunology | Genital Neoplasms, Female - immunology | Esophageal Neoplasms - immunology | Case-Control Studies | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Brain Neoplasms - immunology | Colorectal Neoplasms - immunology | Confounding Factors (Epidemiology) | Neoplasms - immunology | Thyroid Neoplasms - immunology | Pancreatic Neoplasms - immunology | Urinary Bladder Neoplasms - immunology | Female | Hypersensitivity - epidemiology | Hematologic Neoplasms - immunology | Research Design | Neoplasms - epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights